Jay Moyes

Mr. Jay M.
Moyes is an Independent Director at SINTX Technologies, Inc., a Lead Independent Director at Puma Biotechnology, Inc., an Independent Director at BioCardia, Inc., a Managing Member at Drayton Investments LLC and a Member at Utah Association of Certified Public Accountants.
He is on the Board of Directors at SINTX Technologies, Inc., Puma Biotechnology, Inc. and BioCardia, Inc. Mr. Moyes was previously employed as a Chief Financial Officer & Treasurer by Sera Prognostics, Inc., an Independent Director by Predictive Technology Group, Inc., an Independent Director by Achieve Life Sciences, Inc., an Independent Director by Integrated Diagnostics, Inc., a Chief Financial Officer by XDx, Inc., an Independent Non-Executive Director by Osiris Therapeutics, Inc., a Trustee by Utah Life Science Association, a Chief Financial Officer by Myriad Genetics, Inc., a Chief Financial Officer & Vice President-Finance by Genmarks, Inc., and a Senior Manager by KPMG LLP.
He also served on the board at BioCardia, Inc. /Old/.
He received his undergraduate degree from Weber State University and an MBA from the University of Utah.